 |
|
|
| |
C-EDGE: INTEGRATED ANALYSIS FROM THE PHASE 2/3 STUDIES OF ELBASVIR / GRAZOPREVIR IN PATIENTS WITH HCV/HIV (2)
|
| |
| |
Reported by Jules Levin
IDSA 2015 Oct 7-11 San Diego, CA
Nelson, M, Rockstroh J, Mallolas J, Katlama C, Nahass R, Saag M, Sulkowski M, Howe A, Hwang P, Nguyen B-Y, Wahl J, Barr E, Robertson M, Haber B, Platt H.
|
| |
|
|
|
|
|
